カテゴリー： Market Monitor Global, 世界, 医療/バイオ

遺伝子送達/遺伝子治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Gene Delivery or Gene Therapy Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5583）

◆商品コード：MMG23JU5583
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：67
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Gene Delivery or Gene Therapy Drug Market 調査レポートは次の情報を含め、グローバルにおけるの遺伝子送達/遺伝子治療薬市場規模と予測を収録しています。・世界の遺伝子送達/遺伝子治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の遺伝子送達/遺伝子治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の遺伝子送達/遺伝子治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ウイルス遺伝子送達システム」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

遺伝子送達/遺伝子治療薬のグローバル主要企業は、Biogen、 Novartis、 Gilead Sciences、 Sarepta Therapeutics、 Alnylam Pharmaceuticals、 Amgen、 Spark Therapeutics、 Akcea Therapeutics、 Sunway Biotech、 SIBIONO、 AnGes、 Orchard Therapeutics、 Human Stem Cells Instituteなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、遺伝子送達/遺伝子治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の遺伝子送達/遺伝子治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の遺伝子送達/遺伝子治療薬市場：タイプ別市場シェア、2022年
・ウイルス遺伝子送達システム、非ウイルス遺伝子送達システム

世界の遺伝子送達/遺伝子治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の遺伝子送達/遺伝子治療薬市場：用途別市場シェア、2022年
・神経疾患、がん、その他

世界の遺伝子送達/遺伝子治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の遺伝子送達/遺伝子治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における遺伝子送達/遺伝子治療薬のグローバル売上、2018年-2023年
・主要企業における遺伝子送達/遺伝子治療薬のグローバル売上シェア、2022年
・主要企業における遺伝子送達/遺伝子治療薬のグローバル販売量、2018年-2023年
・主要企業における遺伝子送達/遺伝子治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Biogen、 Novartis、 Gilead Sciences、 Sarepta Therapeutics、 Alnylam Pharmaceuticals、 Amgen、 Spark Therapeutics、 Akcea Therapeutics、 Sunway Biotech、 SIBIONO、 AnGes、 Orchard Therapeutics、 Human Stem Cells Institute

*************************************************************

・調査・分析レポートの概要
遺伝子送達/遺伝子治療薬市場の定義
市場セグメント
世界の遺伝子送達/遺伝子治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の遺伝子送達/遺伝子治療薬市場規模
世界の遺伝子送達/遺伝子治療薬市場規模：2022年 VS 2029年
世界の遺伝子送達/遺伝子治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの遺伝子送達/遺伝子治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の遺伝子送達/遺伝子治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ウイルス遺伝子送達システム、非ウイルス遺伝子送達システム
遺伝子送達/遺伝子治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：神経疾患、がん、その他
遺伝子送達/遺伝子治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別遺伝子送達/遺伝子治療薬市場規模 2022年と2029年
地域別遺伝子送達/遺伝子治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Biogen、 Novartis、 Gilead Sciences、 Sarepta Therapeutics、 Alnylam Pharmaceuticals、 Amgen、 Spark Therapeutics、 Akcea Therapeutics、 Sunway Biotech、 SIBIONO、 AnGes、 Orchard Therapeutics、 Human Stem Cells Institute
...

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery.
This report aims to provide a comprehensive presentation of the global market for Gene Delivery or Gene Therapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery or Gene Therapy Drug. This report contains market size and forecasts of Gene Delivery or Gene Therapy Drug in global, including the following market information:
Global Gene Delivery or Gene Therapy Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene Delivery or Gene Therapy Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Viral Gene Delivery System Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene Delivery or Gene Therapy Drug include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Delivery or Gene Therapy Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Delivery or Gene Therapy Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene Delivery or Gene Therapy Drug Market Segment Percentages, by Type, 2022 (%)
Viral Gene Delivery System
Non-viral Gene Delivery System
Global Gene Delivery or Gene Therapy Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene Delivery or Gene Therapy Drug Market Segment Percentages, by Application, 2022 (%)
Neurological Diseases
Cancer
Other
Global Gene Delivery or Gene Therapy Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene Delivery or Gene Therapy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Delivery or Gene Therapy Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Delivery or Gene Therapy Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Delivery or Gene Therapy Drug, market overview.
Chapter 2: Global Gene Delivery or Gene Therapy Drug market size in revenue.
Chapter 3: Detailed analysis of Gene Delivery or Gene Therapy Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Delivery or Gene Therapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Gene Delivery or Gene Therapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Delivery or Gene Therapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Delivery or Gene Therapy Drug Overall Market Size
2.1 Global Gene Delivery or Gene Therapy Drug Market Size: 2022 VS 2029
2.2 Global Gene Delivery or Gene Therapy Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Delivery or Gene Therapy Drug Players in Global Market
3.2 Top Global Gene Delivery or Gene Therapy Drug Companies Ranked by Revenue
3.3 Global Gene Delivery or Gene Therapy Drug Revenue by Companies
3.4 Top 3 and Top 5 Gene Delivery or Gene Therapy Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Delivery or Gene Therapy Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Delivery or Gene Therapy Drug Players in Global Market
3.6.1 List of Global Tier 1 Gene Delivery or Gene Therapy Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Delivery or Gene Therapy Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Gene Delivery or Gene Therapy Drug Market Size Markets, 2022 & 2029
4.1.2 Viral Gene Delivery System
4.1.3 Non-viral Gene Delivery System
4.2 By Type – Global Gene Delivery or Gene Therapy Drug Revenue & Forecasts
4.2.1 By Type – Global Gene Delivery or Gene Therapy Drug Revenue, 2018-2023
4.2.2 By Type – Global Gene Delivery or Gene Therapy Drug Revenue, 2024-2029
4.2.3 By Type – Global Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gene Delivery or Gene Therapy Drug Market Size, 2022 & 2029
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application – Global Gene Delivery or Gene Therapy Drug Revenue & Forecasts
5.2.1 By Application – Global Gene Delivery or Gene Therapy Drug Revenue, 2018-2023
5.2.2 By Application – Global Gene Delivery or Gene Therapy Drug Revenue, 2024-2029
5.2.3 By Application – Global Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Gene Delivery or Gene Therapy Drug Market Size, 2022 & 2029
6.2 By Region – Global Gene Delivery or Gene Therapy Drug Revenue & Forecasts
6.2.1 By Region – Global Gene Delivery or Gene Therapy Drug Revenue, 2018-2023
6.2.2 By Region – Global Gene Delivery or Gene Therapy Drug Revenue, 2024-2029
6.2.3 By Region – Global Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Gene Delivery or Gene Therapy Drug Revenue, 2018-2029
6.3.2 US Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.3.3 Canada Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.3.4 Mexico Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Gene Delivery or Gene Therapy Drug Revenue, 2018-2029
6.4.2 Germany Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.4.3 France Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.4.4 U.K. Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.4.5 Italy Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.4.6 Russia Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.4.7 Nordic Countries Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.4.8 Benelux Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Gene Delivery or Gene Therapy Drug Revenue, 2018-2029
6.5.2 China Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.5.3 Japan Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.5.4 South Korea Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.5.5 Southeast Asia Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.5.6 India Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Gene Delivery or Gene Therapy Drug Revenue, 2018-2029
6.6.2 Brazil Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.6.3 Argentina Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Gene Delivery or Gene Therapy Drug Revenue, 2018-2029
6.7.2 Turkey Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.7.3 Israel Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
6.7.5 UAE Gene Delivery or Gene Therapy Drug Market Size, 2018-2029
7 Gene Delivery or Gene Therapy Drug Companies Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene Delivery or Gene Therapy Drug Major Product Offerings
7.1.4 Biogen Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene Delivery or Gene Therapy Drug Major Product Offerings
7.2.4 Novartis Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene Delivery or Gene Therapy Drug Major Product Offerings
7.3.4 Gilead Sciences Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Major Product Offerings
7.4.4 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.4.5 Sarepta Therapeutics Key News & Latest Developments
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.5.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene Delivery or Gene Therapy Drug Major Product Offerings
7.6.4 Amgen Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene Delivery or Gene Therapy Drug Major Product Offerings
7.7.4 Spark Therapeutics Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.7.5 Spark Therapeutics Key News & Latest Developments
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Major Product Offerings
7.8.4 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.8.5 Akcea Therapeutics Key News & Latest Developments
7.9 Sunway Biotech
7.9.1 Sunway Biotech Company Summary
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Gene Delivery or Gene Therapy Drug Major Product Offerings
7.9.4 Sunway Biotech Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.9.5 Sunway Biotech Key News & Latest Developments
7.10 SIBIONO
7.10.1 SIBIONO Company Summary
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Gene Delivery or Gene Therapy Drug Major Product Offerings
7.10.4 SIBIONO Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.10.5 SIBIONO Key News & Latest Developments
7.11 AnGes
7.11.1 AnGes Company Summary
7.11.2 AnGes Business Overview
7.11.3 AnGes Gene Delivery or Gene Therapy Drug Major Product Offerings
7.11.4 AnGes Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.11.5 AnGes Key News & Latest Developments
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Company Summary
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Major Product Offerings
7.12.4 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.12.5 Orchard Therapeutics Key News & Latest Developments
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Company Summary
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Major Product Offerings
7.13.4 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Revenue in Global Market (2018-2023)
7.13.5 Human Stem Cells Institute Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Gene Delivery or Gene Therapy Drug Market Opportunities & Trends in Global Market
Table 2. Gene Delivery or Gene Therapy Drug Market Drivers in Global Market
Table 3. Gene Delivery or Gene Therapy Drug Market Restraints in Global Market
Table 4. Key Players of Gene Delivery or Gene Therapy Drug in Global Market
Table 5. Top Gene Delivery or Gene Therapy Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Delivery or Gene Therapy Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Delivery or Gene Therapy Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Delivery or Gene Therapy Drug Product Type
Table 9. List of Global Tier 1 Gene Delivery or Gene Therapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Delivery or Gene Therapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene Delivery or Gene Therapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Delivery or Gene Therapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene Delivery or Gene Therapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Delivery or Gene Therapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene Delivery or Gene Therapy Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Delivery or Gene Therapy Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 30. Biogen Company Summary
Table 31. Biogen Gene Delivery or Gene Therapy Drug Product Offerings
Table 32. Biogen Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Biogen Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Gene Delivery or Gene Therapy Drug Product Offerings
Table 36. Novartis Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Gilead Sciences Company Summary
Table 39. Gilead Sciences Gene Delivery or Gene Therapy Drug Product Offerings
Table 40. Gilead Sciences Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Gilead Sciences Key News & Latest Developments
Table 42. Sarepta Therapeutics Company Summary
Table 43. Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Product Offerings
Table 44. Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Sarepta Therapeutics Key News & Latest Developments
Table 46. Alnylam Pharmaceuticals Company Summary
Table 47. Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Product Offerings
Table 48. Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Alnylam Pharmaceuticals Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Gene Delivery or Gene Therapy Drug Product Offerings
Table 52. Amgen Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Spark Therapeutics Company Summary
Table 55. Spark Therapeutics Gene Delivery or Gene Therapy Drug Product Offerings
Table 56. Spark Therapeutics Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Spark Therapeutics Key News & Latest Developments
Table 58. Akcea Therapeutics Company Summary
Table 59. Akcea Therapeutics Gene Delivery or Gene Therapy Drug Product Offerings
Table 60. Akcea Therapeutics Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Akcea Therapeutics Key News & Latest Developments
Table 62. Sunway Biotech Company Summary
Table 63. Sunway Biotech Gene Delivery or Gene Therapy Drug Product Offerings
Table 64. Sunway Biotech Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Sunway Biotech Key News & Latest Developments
Table 66. SIBIONO Company Summary
Table 67. SIBIONO Gene Delivery or Gene Therapy Drug Product Offerings
Table 68. SIBIONO Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 69. SIBIONO Key News & Latest Developments
Table 70. AnGes Company Summary
Table 71. AnGes Gene Delivery or Gene Therapy Drug Product Offerings
Table 72. AnGes Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 73. AnGes Key News & Latest Developments
Table 74. Orchard Therapeutics Company Summary
Table 75. Orchard Therapeutics Gene Delivery or Gene Therapy Drug Product Offerings
Table 76. Orchard Therapeutics Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Orchard Therapeutics Key News & Latest Developments
Table 78. Human Stem Cells Institute Company Summary
Table 79. Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Product Offerings
Table 80. Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Human Stem Cells Institute Key News & Latest Developments
List of Figures
Figure 1. Gene Delivery or Gene Therapy Drug Segment by Type in 2022
Figure 2. Gene Delivery or Gene Therapy Drug Segment by Application in 2022
Figure 3. Global Gene Delivery or Gene Therapy Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Delivery or Gene Therapy Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene Delivery or Gene Therapy Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Delivery or Gene Therapy Drug Revenue in 2022
Figure 8. By Type - Global Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 16. US Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 20. Germany Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 28. China Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene Delivery or Gene Therapy Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene Delivery or Gene Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Biogen Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Gilead Sciences Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Spark Therapeutics Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Akcea Therapeutics Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sunway Biotech Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. SIBIONO Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AnGes Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Orchard Therapeutics Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 遺伝子送達/遺伝子治療薬の世界市場見通し2023年-2029年(Gene Delivery or Gene Therapy Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

遺伝子送達/遺伝子治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp